The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
Open accessAbstract
An unresolved question in cardiac biology is whether distinct signaling pathways are responsible for the development of pathological and physiological cardiac hypertrophy in the adult. Physiological hypertrophy is characterized by a normal organization of cardiac structure and normal or enhanced cardiac function, whereas pathological hypertrophy is associated with an altered pattern of cardiac gene expression, fibrosis, cardiac dysfunction, and increased morbidity and mortality. The elucidation of signaling cascades that play distinct roles in these two forms of hypertrophy will be critical for the development of more effective strategies to treat heart failure. We examined the role of the p110α isoform of phosphoinositide 3-kinase (PI3K) for the induction of pathological hypertrophy (pressure overload-induced) and physiological hypertrophy (exercise-induced) by using transgenic mice expressing a dominant negative (dn) PI3K(p110α) mutant specifically in the heart. dnPI3K transgenic mice displayed significant hypertrophy in response to pressure overload but not exercise training. dnPI3K transgenic mice also showed significant dilation and cardiac dysfunction in response to pressure overload. Thus, PI3K(p110α) appears to play a critical role for the induction of physiological cardiac growth but not pathological growth. PI3K(p110α) also appears essential for maintaining contractile function in response to pathological stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Signalling through the lipid products of phosphoinositide-3-OH kinase
Toker, A., & Cantley, L. C. (1997) · Nature · doi:10.1038/42648 · Cited by 1,304
Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
Izumo, S., Nadal-Ginard, B., & Mahdavi, V (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.339 · Cited by 867
Self-citationThe MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Chan, T. O., Rittenhouse, S. E., & Tsichlis, P. N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.965 · Cited by 737
Transgenic Gαq overexpression induces cardiac contractile failure in mice
D’Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B., & Dorn, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8121 · Cited by 629
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
Shioi, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2537 · Cited by 604
Self-citationRegulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways
Crackower, M. A., Oudit, G. Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00969-8 · Cited by 576
Self-citationActivated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462
Self-citationPrevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition
Sussman, M. A., Lim, H. W., Gude, N., Taigen, T., Olson, E. N., Robbins, J., Colbert, M. C., Gualberto, A., Wieczorek, D. F., & Molkentin, J. D. (1998) · Science · doi:10.1126/science.281.5383.1690 · Cited by 461
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
Akhter, S. A., Luttrell, L. M., Rockman, H. A., Iaccarino, G., Lefkowitz, R. J., & Koch, W. J. (1998) · Science · doi:10.1126/science.280.5363.574 · Cited by 452
Colao, A., Marzullo, P., Di Somma, C., & Lombardi, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01218.x · Cited by 388
Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy
Wakasaki, H., Koya, D., Schoen, F. J., Jirousek, M. R., Ways, D. K., Hoit, B. D., Walsh, R. A., & King, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9320 · Cited by 379
Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 377
Wettschureck, N., Rütten, H., Zywietz, A., Gehring, D., Wilkie, T. M., Chen, J., Chien, K. R., & Offermanns, S. (2001) · Nature Medicine · doi:10.1038/nm1101-1236 · Cited by 373
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
IMPACT OF DIFFERENT SPORTS AND TRAINING ON CARDIAC STRUCTURE AND FUNCTION
Fagard, R. H. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70348-9 · Cited by 236
Bowman, J. C., Steinberg, S. F., Jiang, T., Geenen, D. L., Fishman, G. I., & Buttrick, P. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119755 · Cited by 229
Cohn, J. N., Bristow, M. R., Chien, K. R., Colucci, W. S., Frazier, O. H., Leinwand, L. A., Lorell, B. H., Moss, A. J., Sonnenblick, E. H., Walsh, R. A., et al. (1997) · Circulation · doi:10.1161/01.cir.95.4.766 · Cited by 219
Neri Serneri, G. G., Boddi, M., Modesti, P. A., Cecioni, I., Coppo, M., Padeletti, L., Michelucci, A., Colella, A., & Galanti, G. (2001) · Circulation Research · doi:10.1161/hh2301.100982 · Cited by 216
Cook, S. A., Sugden, P. H., & Clerk, A. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0979 · Cited by 213
The role of the Grb2–p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis
Zhang, S., Weinheimer, C., Courtois, M., Kovacs, A., Zhang, C. E., Cheng, A. M., Wang, Y., & Muslin, A. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16290 · Cited by 213
Naga Prasad, S. V., Esposito, G., Mao, L., Koch, W. J., & Rockman, H. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4693 · Cited by 204
Serneri, G. G. N., Boddi, M., Cecioni, I., Vanni, S., Coppo, M., Papa, M. L., Bandinelli, B., Bertolozzi, I., Polidori, G., Toscano, T., et al. (2001) · Circulation Research · doi:10.1161/hh0901.089882 · Cited by 197
Ahdieh, M., Vandenbos, T., & Youakim, A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.6.c2029 · Cited by 183
Growth of the heart in health and disease
Zak, R. (1984) · Raven Press eBooks · Cited by 175
Choukroun, G., Hajjar, R., Fry, S., del Monte, F., Haq, S., Guerrero, J. L., Picard, M., Rosenzweig, A., & Force, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6350 · Cited by 174
Sadoshima, J., Montagne, O., Wang, Q., Yang, G., Warden, J., Liu, J., Takagi, G., Karoor, V., Hong, C., Johnson, G. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14938 · Cited by 167
Calcineurin and cardiac hypertrophy: Where have we been? Where are we going?
Wilkins, B. J., & Molkentin, J. D. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.017129 · Cited by 164
Kodama, Y., Umemura, Y., Nagasawa, S., Beamer, W. G., Donahue, L. R., Rosen, C. R., Baylink, D. J., & Farley, J. R. (2000) · Calcified Tissue International · doi:10.1007/s002230010060 · Cited by 162
Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
Koziris, L. P., Hickson, R. C., Chatterton, R. T., Groseth, R. T., Christie, J. M., Goldflies, D. G., & Unterman, T. G. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.86.4.1436 · Cited by 157
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T., FUJII, N. L., Miyazaki, H., Matsuda, M., & Yamaguchi, I. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r2029 · Cited by 157
Ding, B., Price, R. L., Borg, T. K., Weinberg, E. O., Halloran, P. F., & Lorell, B. H. (1999) · Circulation Research · doi:10.1161/01.res.84.6.729 · Cited by 153
Converging Pathways and Principles in Heart Development and Disease
Chien, K. R., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00834-6 · Cited by 144
Liao, Y., Ishikura, F., Beppu, S., Asakura, M., Takashima, S., Asanuma, H., Sanada, S., Kim, J., Ogita, H., Kuzuya, T., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00238.2001 · Cited by 137
Esposito, G., Prasad, S. V. N., Rapacciuolo, A., Mao, L., Koch, W. J., & Rockman, H. A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1453 · Cited by 135
Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency.
Lembo, G., Rockman, H. A., Hunter, J. J., Steinmetz, H., Koch, W. J., Ma, L., Prinz, M. P., Ross, J., Chien, K. R., & Powell-Braxton, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119086 · Cited by 132
Sadoshima, J., Montagne, O., Wang, Q., Yang, G., Warden, J., Liu, J., Takagi, G., Karoor, V., Hong, C., Johnson, G. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214938 · Cited by 129
Cardiac adaptations to chronic exercise in mice
Kaplan, M. L., Cheslow, Y., Vikstrom, K. L., et al. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.3.h1167 · Cited by 113
Alterations in Gene Expression in the Rat Heart After Chronic Pathological and physiological Loads
Buttrick, P. M., Kaplan, M., Leinwand, L. A., & Scheuer, J. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1008 · Cited by 110
Nakamura, A., Yoshida, K., Takeda, S., Dohi, N., & Ikeda, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02739-4 · Cited by 99
ε Protein Kinase C in Pathological Myocardial Hypertrophy
Wu, G., Toyokawa, T., Hahn, H. H., & Dorn, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000380200 · Cited by 77
l -Arginine enhances aerobic exercise capacity in association with augmented nitric oxide production
Maxwell, A. J., Ho, H. –. V., Le, C. Q., Lin, P. S., Bernstein, D., & Cooke, J. P. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.3.933 · Cited by 71
Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice
Harrison, B. C., Bell, M. L., Allen, D. L., Byrnes, W. C., & Leinwand, L. A. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00832.2001 · Cited by 58
Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats
Yeh, J. K., Aloia, J. F., Chen, M., et al. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.1.e129 · Cited by 58
Therapeutic options in minimizing left ventricular hypertrophy
Devereux, R. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.102902 · Cited by 44
Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat
Geenen, D. L., Malhotra, A., & Buttrick, P. M. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.2.816 · Cited by 29
Cited by
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationRegulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Self-citationPhysiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
Metadata
- Authors
- McMullen, J. R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M. C., Kang, P. M., & Izumo, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-09-24
- Volume
- 100
- Issue
- 21
- Pages
- 12355-12360
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2115013104
- Cited by
- 534
- References
- 50
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.